CHMFL-BMX-078
CAS: 1808288-51-8
Ref. 3D-IXC28851
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar |
Información del producto
CHMFL-BMX-078 is a covalent inhibitor that targets the tyrosine kinase of activated cancer cells. It has been shown to be an effective treatment for cancers with activating mutations in the epidermal growth factor receptor (EGFR) gene, such as non-small cell lung cancer and colorectal cancer. CHMFL-BMX-078 has also been used in clinical trials for patients with metastatic solid tumours who have not responded to standard therapy. This drug has also been shown to be safe and tolerable at doses of up to 100 mg/kg per day, with no significant adverse effects.
Propiedades químicas
Consulta técnica sobre: 3D-IXC28851 CHMFL-BMX-078
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
